Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital. 2019

Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
Department of Microbiology and Biochemistry, Faculty of Natural and Life Sciences University of Batna 2, Batna, Algeria. m.merradi@univ-batna2.dz.

Pseudomonas aeruginosa is one of the most common nosocomial pathogens, known with a wide resistance to antimicrobials. Carbapenemases producing Pseudomonas aeruginosa is a growing global public health concern as this pathogen is easily transmissible among patients. Metallo-Beta-lactamases is the most important class of these carbapenemases with their broad-spectrum resistance profile. This study was conducted to investigate the prevalence of MBL-producing P. aeruginosa collected in an Algerian hospital. All Metallo-β-lactamase (MBL)-producing P. aeruginosa isolates recovered from patients during a 2 years period (2015-2016) were studied using a combination of phenotypic and molecular typing methods (susceptibility testing, molecular characterization of carbapenemase-encoding genes, multi-locus sequence typing and pulsed-field gel electrophoresis). A total of twenty-six MBL producing P. aeruginosa of 188 isolates were investigated. The burns unit ranked in the first position of the majority of identified cases with 73.07%. About 73.07% of total MBL isolates were mainly isolated from pus samples. The studied isolates were subjected to the molecular typing, in which 4 different Dra1-PFGE patterns and 3 sequences type were assigned (ST244, ST381, and ST1076), and all isolates were revealed positive for VIM-4. We report the third description of blaVIM-4 in Algeria indicating the emergence and spread of carbapenemase-encoding genes among P. aeruginosa in the hospital environment.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection

Related Publications

Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
August 2017, Antimicrobial agents and chemotherapy,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
July 2012, The Journal of antimicrobial chemotherapy,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
June 2011, Journal of medical microbiology,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
September 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
December 2020, Journal of global antimicrobial resistance,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
December 2008, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
March 2022, Microbial drug resistance (Larchmont, N.Y.),
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
March 2015, Infection & chemotherapy,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
August 2021, The Journal of antimicrobial chemotherapy,
Manel Merradi, and Ahmed Kassah-Laouar, and Ammar Ayachi, and Nouzha Heleili, and Taha Menasria, and Didier Hocquet, and Pascal Cholley, and Marlène Sauget
November 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!